INTERLEUKIN-6 AND INTERLEUKIN-8 IN THE URINE OF CHILDREN WITH ACUTE PYELONEPHRITIS

被引:40
作者
TULLUS, K
FITURI, O
BURMAN, LG
WRETLIND, B
BRAUNER, A
机构
[1] Department of Paediatrics, St. Göran's Children's Hospital, Stockholm
[2] Department of Bacteriology, Nauonal Bacteriological Laboratory, Stockholm
[3] Danderyd Hospital, Danderyd
[4] Stockholm County Council Central Microbiological Laboratory, Stockholm, S-107 26
关键词
INTERLEUKIN-6; INTERLEUKIN-8; ACUTE PYELONEPHRITIS; AGE;
D O I
10.1007/BF00866334
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Interleukin-6 (IL-6) and interleukin-8 (IL-8) are important mediators of the inflammatory response in serious bacterial infections. We studied the levels of these two cytokines (standardised for urinary creatinine) in the urine of infants and children during and 6 weeks after acute pyelonephritis and in non-renal febrile controls and healthy children without apparent infection. IL-6 was detected in the urine of 52% of children with pyelonephritis compared with 15% of other children (P <0.001). The median urinary IL-6 level in acute pyelonephritis was 4 pg/mu mol compared with undetectable levels in the control group (P <0.001). IL-8 was detected in 98% of children with pyelonephritis and 42% of other children (P <0.001). The median concentration of IL-8 was 188 pg/mu mol in pyelonephritis; it was undetectable in controls (P <0.001). IL-8 levels were higher in children less than 1 year of age (P <0.001).
引用
收藏
页码:280 / 284
页数:5
相关论文
共 34 条
[31]  
Kennedy W.A., Hoyt M.J., McCracken G.H., The role of corticosteroid therapy in children with pneumococcal meningitis, Am J Dis Child, 145, pp. 1374-1378, (1991)
[32]  
Ohlsson K., Bjork P., Bergenfeldt M., Hageman R., Thompson R.C., Interleukin-1 receptor antagonist reduces moitality from endotoxin shock, Nature, 348, pp. 550-552, (1990)
[33]  
Wakabayashi G., Gelfand J.A., Burke J.F., Thompson R.C., Dinarello C.A., A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits, FASEB J, 5, pp. 338-343, (1991)
[34]  
Fischer E., Marano M.A., Van Zee K.J., Rock C.S., Hawes A.S., Thompson W.A., Deforge L., Kenney J.S., Remick D.G., Bloedow D.C., Thompson R.C., Lowry S.F., Moldawer L.L., Inteneukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia, J Clin Invest, 89, pp. 1551-1557, (1992)